KIMBERLY BOWMAN: Open Payments
NPI 1073889689 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 6 companies in 2025. Trend: 2023 $315 · 2024 $405 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $74 |
| Lilly USA, LLC | 4 | $72 |
| Noctrix Health, Inc. | 1 | $59 |
| ABBVIE INC. | 2 | $36 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Sunosi, NIDRA, MOUNJARO, ZEPBOUND, QULIPTA, Quviviq, CAPLYTA, VRAYLAR.
Industry payments across KY — which companies pay providers there.
